In a recent episode of 340B Leaders Upfront, Verity Solutions’ Chief Growth Officer Brendan Kerrigan and Director of Regulatory, Compliance, and Enablement Kim Pirtle sat down with host Anna Magnum to share their perspectives on the current 340B ecosystem, and offer advice to Covered Entities on long-term success.
Below are the key takeaways from the discussion.
Compliance, Transparency, and End‑to‑End Support Matter More Than Ever
The complexity of today’s 340B environment has increased the need for solutions that are built with compliance and transparency at their core. Verity Solutions takes a connected, cohesive approach to end‑to‑end 340B program administration, automating accumulation, eligibility, replenishment, and audit readiness, as well as tools designed to improve purchasing visibility and price verification through solutions like VERISAVE®.
However, technology alone is not enough. Success comes from pairing advanced tools with expert customer support, which is why the combination of Verity’s extensive education resources and hands‑on account management is a reflection of Verity’s commitment to long‑term partnership.
Policy and Pricing Changes Are an Opportunity for Refining Operations
Covered Entities know how policy decisions can influence day‑to‑day operations. When it comes to integrating new policies, like the recent Medicare Drug Price Negotiation requirements, Verity takes a forward-thinking approach to building tangible solutions. To help Covered Entities incorporate MFP in their workflows, Verity has developed new reimbursement flows, provided support for maximum fair price (MFP) files, and added reporting considerations.
Navigating these dynamics requires careful financial assessment and operational discipline to sustain programs and services, and these changes reinforce the need for strong administrative infrastructure and clear visibility across purchasing and inventory workflows.
Resilience Relies on a Strong Mission and Agility
Looking towards the future, Verity encourages Covered Entities to remain anchored in the “why” of 340B—supporting patients who rely on access to care—while staying agile in response to ongoing policy and market changes. Resilience is strengthened by having proactive partners who are focused on long-term success and harness innovation to support the 340B mission.
A Program Influenced by Change and Defined by Collaboration
As the 340B program continued to evolve, Covered Entities should know they are not navigating these changes alone. Operational precision, fact‑based decision‑making, and collaboration across the 340B community remain essential tools for managing complexity and sustaining access to care.
To hear the entire conversation and deeper insights from Brendan and Kim, listen to the full episode of 340B Leaders Upfront from 340B Report.
Build and manage your 340B program on one platform, with solutions you can combine to capture eligible prescriptions, maximize savings, and stay audit-ready.
Manage rising costs and unpredictable drug pricing by automatically finding the best price on every order.